Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Aspirin (niedrig dosiert) – Forschungsarchiv – Seite 16 von 60 | SupStack

Aspirin (niedrig dosiert) – Forschungsarchiv

Studien 1701–1750 von 3914, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

1701RCT2011

Barry EL, Mott LA, Sandler RS, Ahnen DJ, Baron JA · Cancer Prev Res (Phila) (2011)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Aspirin (niedrig dosiert) – Forschungsarchiv

Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.

[Series, clinical study from Japan and its reflections; Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial].

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.

Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial.

The International Stroke Trial database.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Dysmenorrhoea.

Platelet response to aspirin 50 and 100 mg in patients with coronary heart disease over a five-year period.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction.

The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.

Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.

Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study.

Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.

Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.

Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot).

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.

Bleeding evaluation during single tooth extraction in patients with coronary artery disease and acetylsalicylic acid therapy suspension: a prospective, double-blinded, and randomized study.

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.

The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.

Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.

Use of aspirin associates with longer primary patency of hemodialysis grafts.

The role of aspirin in childhood tuberculous meningitis.

Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO).

Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.

The effects of high- and low-dose aspirin on thermoregulation during and after acute cold exposure.

Reconsidering low-dose aspirin therapy for cardiovascular disease: a study protocol for physician and patient behavioral change.

Evaluation of bioequivalence between a single-capsule formulation of esomeprazole 40 mg and acetylsalicylic acid 325 mg and the monotherapies given separately in healthy volunteers.

Accrual and drop out in a primary prevention randomised controlled trial: qualitative study.

Aspirin-induced small bowel injuries and the preventive effect of rebamipide.

Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial.

Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial.

Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study.

Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT.

Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation.

Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis.

Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.

Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds - gastrointestinal adverse effects: a meta-analysis of randomized clinical trials.

Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial.

"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.

Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin.